Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Efficacy of gabapentin in the treatment of SUNCT syndrome.
Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.
Active Suppression Induced by Repetitive Self-Epitopes Protects against EAE Development.
Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.
Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
MicroRNA and Transcriptional Crosstalk in Myelinating Glia.
Myeloproliferative neoplasms in five multiple sclerosis patients.
Medical image. Neuromyelitis optica masquerading as sepsis.
PAMP-DAMPs interactions mediates development and progression of multiple sclerosis.
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
"Nine" syndrome: A new neuro-ophthalmologic syndrome: Report of two cases.
Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: The impact of thalamic subnuclei on disability.
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
Elevated CNS inflammation in patients with preclinical Alzheimer's disease.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
Neural correlates of episodic future thinking impairment in multiple sclerosis patients.
Optic neuritis with positive HLA-B27: Characteristic phenotype in the Chinese population.
Evaluation of plaque detection and optimum time of enhancement in acute attack multiple sclerosis after contrast injection.
Thy28 protects against anti-CD3-mediated thymic cell death in vivo.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
Pages
« first
‹ previous
…
635
636
637
638
639
640
641
642
643
…
next ›
last »